In cases of HLH/MAS, hyperferritinemia, and liver involvement, the IL-1 inhibitors or the IL-6 receptor inhibitor (Tocilizumab) [40] as well as the JAK inhibitors (Tofacitinib, Baricitinib) [41,42] are very useful. The gene discussed is IL1B; the disease is macrophage activation syndrome.